These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 7533456)

  • 41. Evaluation of the effect of spinal cord injury on serum PSA levels.
    Konety BR; Nguyen TT; Brenes G; Lewis N; Saul M; Nelson JB; Getzenberg RH
    Urology; 2000 Jul; 56(1):82-6. PubMed ID: 10869630
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Some analytical considerations on the measurement of prostate-specific antigen.
    Blijenberg BG; Kranse R; Eman I; Schröder FH
    Eur J Clin Chem Clin Biochem; 1996 Oct; 34(10):817-21. PubMed ID: 8933105
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Two-year stability of free and total PSA in frozen serum samples.
    Woodrum D; York L
    Urology; 1998 Aug; 52(2):247-51. PubMed ID: 9697789
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Longitudinal changes of benign prostate-specific antigen and [-2]proprostate-specific antigen in seven years in a community-based sample of men.
    Rhodes T; Jacobson DJ; McGree ME; St Sauver JL; Girman CJ; Lieber MM; Klee GG; Demissie K; Jacobsen SJ
    Urology; 2012 Mar; 79(3):655-61. PubMed ID: 22386420
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Variation in measurement of prostate-specific antigen: importance of method and lot variability.
    Wener MH; Daum PR; Brawer MK
    Clin Chem; 1995 Dec; 41(12 Pt 1):1730-7. PubMed ID: 7497613
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The Stability of Prostate-Specific Antigen in Semen Under Various Temperatures.
    Srettabunjong S; Betset P; Limawongpranee S; Ekpo P
    J Forensic Sci; 2015 Nov; 60(6):1577-81. PubMed ID: 26174794
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Measurement of prostate-specific antigen by use of a novel blood collection and analytical system.
    Grzeda BR; Le Bui T; Warner CN; Pirucki TL; Dewey LM; Babich M; Maggiore JA
    Clin Chem; 2002 Aug; 48(8):1272-8. PubMed ID: 12142384
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Validation of neurokinin a assays in the United States and Europe.
    Mamikunian P; Ardill JE; O'Dorisio TM; Krutzik SR; Vinik AI; Go VL; Armstrong L; Mamikunian G; Woltering EA
    Pancreas; 2011 Oct; 40(7):1000-5. PubMed ID: 21926539
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Analytical performance of thrombospondin-1 and cathepsin D immunoassays part of a novel CE-IVD marked test as an aid in the diagnosis of prostate cancer.
    Macagno A; Athanasiou A; Wittig A; Huber R; Weber S; Keller T; Rhiel M; Golding B; Schiess R
    PLoS One; 2020; 15(5):e0233442. PubMed ID: 32421745
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Variance function as basis for assessment of test performance: methodological studies with two assays of prostate-specific antigen.
    Hänseler E; Keller B; Keller H
    Clin Chem; 1994 Nov; 40(11 Pt 1):2046-52. PubMed ID: 7525116
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The Effects of Long-term Storage on Commonly Measured Serum Analyte Levels.
    Kleeberger C; Shore D; Gunter E; Sandler DP; Weinberg CR
    Epidemiology; 2018 May; 29(3):448-452. PubMed ID: 29384792
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Stability of total and free prostate specific antigen in serum submitted to intermittent cold storage conditions.
    El Ezzi AA; El-Saidi MA
    Indian J Clin Biochem; 2009 Apr; 24(2):166-74. PubMed ID: 23105827
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Sixteen-year longitudinal changes in serum prostate-specific antigen levels: the olmsted county study.
    Jacobsen SJ; Jacobson DJ; McGree ME; St Sauver JL; Klee GG; Girman CJ; Lieber MM
    Mayo Clin Proc; 2012 Jan; 87(1):34-40. PubMed ID: 22212966
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Benign prostate specific antigen distribution and associations with urological outcomes in community dwelling black and white men.
    Rhodes T; Jacobson DJ; McGree ME; St Sauver JL; Sarma AV; Girman CJ; Lieber MM; Klee GG; Demissie K; Jacobsen SJ
    J Urol; 2012 Jan; 187(1):87-91. PubMed ID: 22093190
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Distribution and associations of [-2]proenzyme-prostate specific antigen in community dwelling black and white men.
    Rhodes T; Jacobson DJ; McGree ME; St Sauver JL; Sarma AV; Girman CJ; Lieber MM; Klee GG; Demissie K; Jacobsen SJ
    J Urol; 2012 Jan; 187(1):92-6. PubMed ID: 22093189
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Estimation of prostate size in community-dwelling men.
    Jacobson DJ; St Sauver JL; Parker AS; McGree ME; Sarma AV; Girman CJ; Lieber MM; Jacobsen SJ
    Urology; 2011 Feb; 77(2):422-6. PubMed ID: 20800880
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Free/total PSA ratio in clinical and ambulatory application. Are different cutoffs justified?].
    Swoboda A; Luboldt HJ; Rübben H; Börgermann C
    Urologe A; 2009 Sep; 48(9):1002, 1004, 1006-7. PubMed ID: 19693481
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Prostate-specific antigen testing of older men.
    Carter HB; Landis PK; Metter EJ; Fleisher LA; Pearson JD
    J Natl Cancer Inst; 1999 Oct; 91(20):1733-7. PubMed ID: 10528023
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Stability of serum prostate-specific antigen determination across laboratory, assay, and storage time.
    Jacobsen SJ; Klee GG; Lilja H; Wright GL; Oesterling JE
    Urology; 1995 Mar; 45(3):447-53. PubMed ID: 7533456
    [TBL] [Abstract][Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.